Peripheral Lymphocyte Subsets Predict Efficacy and Overall Survival in Gastric Cancer Patients Receiving Preoperative Chemotherapy: A Retrospective Cohort Study
Cancer Reports · 2026
DOI: 10.1002/cnr2.70704 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Cancer Reports, 2026. Verfasst von Zirui Xue und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Zhongshan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Lymphocyte Subsets, Antineoplastic Combined Chemotherapy Protocols, Neoadjuvant Therapy. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Project of Science and Technology of Xiamen City, National Youth Science Fund Project of National Natural Science Foundation of China.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Pathologic complete response (pCR), which reflects the local immune status and preoperative chemotherapy efficacy, has garnered significant attention in gastric cancer research. However, the predictive value of peripheral lymphocyte subsets for pCR in gastric cancer patients receiving preoperative chemotherapy remains unclear.
Aims
This study aims to assess the correlation between preoperative peripheral lymphocyte subsets and pCR in gastric cancer patients. Methods and Results In this retrospective study, gastric cancer patients who underwent curative gastrectomy following preoperative chemotherapy were included. Cytokines and peripheral lymphocytes were measured using flow cytometry. Clinicopathological characteristics, peripheral lymphocyte data and cytokine data were collected for the analysis. Overall survival (OS) was analyzed using Kaplan–Meier curves. Of 173 patients, 15 (8.7%) achieved pCR. A lower proportion of CD19 + B cells (7.5% vs. 10.4%, p = 0.008) was associated with pCR, and a high absolute count of NK cells was associated with better OS ( p = 0.044).
Conclusions
Our study indicated that a lower proportion of CD19 + B cells may serve as a predictive biomarker for pCR, while an increased peripheral NK cell count could function as an auxiliary factor for risk stratification when combined with clinical parameters to assess long‐term outcomes in gastric cancer patients receiving preoperative chemotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
- Gastric Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China.
- Department of General Surgery, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China.
- Xiamen Clinical Research Center for Cancer Therapy, Xiamen, China.
ORCID-Profile: Zirui Xue, Dan Liu, Zhaodong Sun, Bosen Li, Haojie Li, Xuefei Wang, Zhaoming Wang
Förderung
- Project of Science and Technology of Xiamen City
- National Youth Science Fund Project of National Natural Science Foundation of China
Zitieren
APA
Xue, Z., Liu, D., Sun, Z., Li, B., Liu, X., Zhao, J., Li, H., Wang, X., & Wang, Z. (2026). Peripheral Lymphocyte Subsets Predict Efficacy and Overall Survival in Gastric Cancer Patients Receiving Preoperative Chemotherapy: A Retrospective Cohort Study. Cancer Reports. https://doi.org/10.1002/cnr2.70704
Vancouver
Xue Z, Liu D, Sun Z, Li B, Liu X, Zhao J, et al. Peripheral Lymphocyte Subsets Predict Efficacy and Overall Survival in Gastric Cancer Patients Receiving Preoperative Chemotherapy: A Retrospective Cohort Study. Cancer Reports. 2026. doi:10.1002/cnr2.70704
BibTeX
@article{Xue2026,
author = {Xue, Zirui and Liu, Dan and Sun, Zhaodong and Li, Bosen and Liu, Xinyou and Zhao, Junjie and Li, Haojie and Wang, Xuefei and Wang, Zhaoming},
title = {Peripheral Lymphocyte Subsets Predict Efficacy and Overall Survival in Gastric Cancer Patients Receiving Preoperative Chemotherapy: A Retrospective Cohort Study},
journal = {Cancer Reports},
year = {2026},
doi = {10.1002/cnr2.70704}
}
EUVIMED